Fikrig E - Search Results

1

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.

Ledizet M, Kar K, Foellmer HG, Bonafé N, Anthony KG, Gould LH, Bushmich SL, Fikrig E, Koski RA. Ledizet M, et al. Among authors: fikrig e. J Infect Dis. 2007 Dec 15;196(12):1741-8. doi: 10.1086/523654. J Infect Dis. 2007. PMID: 18190253

2

Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA.

Fikrig E, Barthold SW, Kantor FS, Flavell RA. Fikrig E, et al. J Infect Dis. 1991 Dec;164(6):1224-7. doi: 10.1093/infdis/164.6.1224. J Infect Dis. 1991. PMID: 1955724

3

Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease.

Schoen RT, Meurice F, Brunet CM, Cretella S, Krause DS, Craft JE, Fikrig E. Schoen RT, et al. Among authors: fikrig e. J Infect Dis. 1995 Nov;172(5):1324-9. doi: 10.1093/infdis/172.5.1324. J Infect Dis. 1995. PMID: 7594671 Clinical Trial.

4

Lyme disease in human DR4Dw4-transgenic mice.

Feng S, Barthold SW, Bockenstedt LK, Zaller DM, Fikrig E. Feng S, et al. Among authors: fikrig e. J Infect Dis. 1995 Jul;172(1):286-9. doi: 10.1093/infdis/172.1.286. J Infect Dis. 1995. PMID: 7797933

5

Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis.

Fikrig E, Bockenstedt LK, Barthold SW, Chen M, Tao H, Ali-Salaam P, Telford SR, Flavell RA. Fikrig E, et al. J Infect Dis. 1994 Mar;169(3):568-74. doi: 10.1093/infdis/169.3.568. J Infect Dis. 1994. PMID: 8158028

6

Lyme borreliosis in transgenic mice tolerant to OspA from Borrelia burgdorferi 25015.

Fikrig E, Barthold SW, Chen M, Tao H, Ali-Salaam P, Bockenstedt LK, Flavell RA. Fikrig E, et al. J Infect Dis. 1997 Apr;175(4):1000-3. doi: 10.1086/513958. J Infect Dis. 1997. PMID: 9086169

7

Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi.

Barthold SW, Feng S, Bockenstedt LK, Fikrig E, Feen K. Barthold SW, et al. Among authors: fikrig e. Clin Infect Dis. 1997 Jul;25 Suppl 1:S9-17. doi: 10.1086/516166. Clin Infect Dis. 1997. PMID: 9233658

8

The early humoral response in human granulocytic ehrlichiosis.

IJdo JW, Zhang Y, Hodzic E, Magnarelli LA, Wilson ML, Telford SR 3rd, Barthold SW, Fikrig E. IJdo JW, et al. Among authors: fikrig e. J Infect Dis. 1997 Sep;176(3):687-92. doi: 10.1086/514091. J Infect Dis. 1997. PMID: 9291316

9

The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis.

IJdo JW, Meek JI, Cartter ML, Magnarelli LA, Wu C, Tenuta SW, Fikrig E, Ryder RW. IJdo JW, et al. Among authors: fikrig e. J Infect Dis. 2000 Apr;181(4):1388-93. doi: 10.1086/315389. Epub 2000 Apr 4. J Infect Dis. 2000. PMID: 10751139

10

Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands.

Das S, Banerjee G, DePonte K, Marcantonio N, Kantor FS, Fikrig E. Das S, et al. Among authors: fikrig e. J Infect Dis. 2001 Oct 15;184(8):1056-64. doi: 10.1086/323351. Epub 2001 Sep 28. J Infect Dis. 2001. PMID: 11574922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters